FDA Drug Approvals
Posted: Sep 27 2016

Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan. While the medications below have been evaluated and approved by the FDA, they may not enter the marketplace for several weeks or months. Therefore, pricing information for these medications is typically unavailable at the time of approval.

New Brand Approvals
Drug Name Uses/Treatment Pricing Information Other Information
Troxyca ER® (oxycodone and naltrexone) capsule Treatment of adult patients with chronic pain for which alternative treatment options are inadequate. Pricing information not yet available.
  • Drug Information: Troxyca ER is a schedule II opioid that treats chronic, long-term pain.  Troxyca ER combines an opioid agonist with an opioid antagonist within a single capsule to reduce the risk of abuse.
  • Formulary Management: Considered non-preferred upon market entry (pending clinical evaluation).
  • Control Trak:
    • Subject to Max Dollar and Max Dose edits
    • Subject to prior authorization as a component of the Chronic Use Program and Monthly Review for participating health plans
Erelzi™ (Etanercept-SZZS) injectable Treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis in patient aged 2 years or older, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis Pricing information not yet available.
  • Drug Information: Erelzi is a tumor necrosis factor (TNF) blocker; a biosimilar to Enbrel.
  • Formulary Management: Considered non-preferred upon market entry (pending clinical evaluation).
  • BIC Specialty Rx: Comprehensive clinical management and competitive discounts via MedTrakRx’s BIC Specialty Pharmacy Network.
  • Control Trak: Subject to Max Dollar and Max Dose edits.

The Clinical Care Center (CCC) is MedTrakRx’s comprehensive clinical solution to control costs and increase adherence for our Clients and Members. The Clinical Care Center is made up of 7 Steps to Improved Outcomes: Generics Plus, Formulary Management, Member & Client Education, RightChoice, Control Trak, Best-In-Class (BIC) SpecialtyRx, and Clinical Concierge.